The spectrum of AIDS-defining diseases: Temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996

International Journal of Epidemiology

Volumn 28, Issue 5, 1999, Pages 975-981

  Pezzotti, Patrizio ^a   Serraino, Diego ^b   Rezza, Giovanni ^a   Dal Maso, Luigino ^b   Vaccher, Emanuela ^b   Cozzi Lepri, Alessandro ^c   Franceschi, Silvia ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

AIDS defining diseases; Italy; Surveillance; Trends

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE PREVALENCE; HEALTH CARE; MEDICAL GEOGRAPHY; TEMPORAL DISTRIBUTION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; FEMALE; GENDER; HUMAN; ITALY; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOSIS; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTOZOAL INFECTION; REGISTER; TOXOPLASMOSIS; VIRUS INFECTION;

ITALY;

EID: 0032721678     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.5.975     Document Type: Article

References (33)

1. Centro Operativo AIDS. Aggiornamento dei casi di AIDS notificati in Italia al 31 marzo 1997. Notiziario dell'Istituto Superiore di Sanità 1997;10(Suppl.2):1-15.
2. Delmas MC, Schwoebel V, Heisterkamp SH, Downs AM, Ancelle-Park RA, Brunet JB. Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:74-80.
3. + lymphocyte count at diagnosis of acquired immunodeficiency syndrome. J Clin Epidemiol 1996;49:1253-58.
4. Schwoebel V, Delmas MC, Hamers F et al. Tuberculosis as an AIDS-defining disease in Europe. Clin Microbiol Infect 1996;1:286-88.
5. Fusaro RE, Bacchetti P, Jewell NP. A competing risks analysis of presenting AIDS diagnoses trends. Biometrics 1996;52:211-25.
6. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States. MMWR 1985;34:373-75.
7. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36:Suppl.1:15-155.
8. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
9. Ancelle-Park RA. Expanded European AIDS case definition. Lancet 1993;341:441.
10. Powderly WG. Multiple opportunistic infection prophylaxis. AIDS 1996;10:S165-71.
11. Franceschi S, Dal Maso L, Lo Re A, Serraino D, La Vecchia C. Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94. Br J Cancer 1997;76:114-17.
12. Wall PG, Porter K, Noone A, Goldberg DJ. Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United Kingdom. AIDS 1993;7:1523-25.
13. Hermans P, Lundgren J, Sommereijns B et al. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS 1996;10: 911-17.
14. Schwartländer B, Horsburgh CR Jr, Hamouda O, Skarabis H, Koch MA. Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS 1992;6:413-20.
15. Jougla E, Péquignot F, Carbon C et al. AIDS-related conditions: study of a representative sample of 1203 patients deceased in 1992 in France. Int J Epidemiol 1996;25:190-97.
16. Muñoz A, Schrager LK, Bacellar H et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985-1991. Am J Epidemiol 1993; 137:423-38.
17. Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 1995;123:933-36.
18. Cantoni M, Cozzi Lepri A, Grossi P, Pezzotti P, Rezza G, Verdecchia A. Use of AIDS surveillance data to describe subepidemic dynamics. Int J Epidemiol 1995;24:804-12.
19. Conti S, Farchi G, Galletti A et al. La notifica della mortalità per AIDS in Italia (1992): qualità della certificazione e sottonotifica. Giornale Italiano dell'AIDS 1997;8:12-16.
20. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley and Sons, 1989.
21. SAS Institute Inc. SAS Software, Release 6.11, Cary, NC: SAS Institute Inc., 1995.
22. StataCorp. Stata Statistical Software: Release 5.0. College Station, TX: Stata Corporation, 1997.
23. Mocroft A, Youle M, Phillips AN et al. The incidence of AIDS-defining illnesses in 4883 patients with Human Immunodeficiency Virus. Arch Int Med 1998;158:491-97.
24. Montaner JSG, Le T, Hogg R et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994;8:693-96.
25. Napoli PA, Dorrucci M, Serraino D et al. Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii pneumonia (PCP) before AIDS diagnosis in Italy. Eur J Epidemiol 1998;14:41-47.
26. Schwarcz SK, Katz MH, Hirozawa A, Gurley J, Lemp GF. Prevention of Pneumocystis carinii pneumonia: who are we missing. AIDS 1997; 11:1263-68.
27. Hoover DR, Saah AJ, Bacellar H et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329: 1922-26.
28. Schneider MME, Hoepelman AIM, Eeftinck Schattenkerd JKM et al. A controlled trial of aerosolized pentamidine or trimethoprimsulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1836-41.
29. Girard P-M, Landman R, Gaudebout C et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993;328:1514-20.
30. Carr A, Tindall B, Brew BJ et al. Low-dose trimethoprimsulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Inter Med 1992;117:106-11.
31. Saah AJ, Hoover DR, Peng Y et al. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA 1995;273:1197-202.
32. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF. Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe. AIDS 1997;11:649-62.
33. Carr A, Cooper DA. HIV protease inhibitors. AIDS 1996;10:S151-57.